Goserelin acetate before transurethral resection of moderately enlarged benign prostatic hyperplasia: Prospective randomised-controlled clinical trial

OBJECTIVE: To evaluate the impact of a luteinising hormone-releasing hormone (LHRH) agonist, goserelin acetate (GA), on surgical blood loss during transurethral resection of the prostate (TURP), as well as its histopathological effect on prostatic microvessel density (MVD). PATIENTS AND METHODS: Pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arab J Urol
Autors principals: Abo El-Enen, Mohamed, Tawfik, Ahmed, El-Abd, Ahmed S., Ragab, Maged, El-Abd, Sherin, Elrashidy, Mohamed, Elmashad, Nehal, Rasheed, Mohamed, El-Abd, Shawky
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2016
Matèries:
Prostatic Disorders Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4767797/
https://ncbi.nlm.nih.gov/pubmed/26966595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.aju.2015.09.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars